On Monday, Atyr Pharma Inc (NASDAQ: ATYR) opened higher 5.66% from the last session, before settling in for the closing price of $5.83. Price fluctuations for ATYR have ranged from $1.67 to $7.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 34.28%. Company’s average yearly earnings per share was noted 28.86% at the time writing. With a float of $86.06 million, this company’s outstanding shares have now reached $89.00 million.
Considering the fact that the conglomerate employs 59 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atyr Pharma Inc is 3.31%, while institutional ownership is 68.87%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 28.86% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Check out the current performance indicators for Atyr Pharma Inc (ATYR). In the past quarter, the stock posted a quick ratio of 7.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Compared to the last year’s volume of 2.2 million, its volume of 9.72 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 34.28%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 77.35%, which indicates a significant increase from 49.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.62 in the past 14 days, which was higher than the 0.36 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.05, while its 200-day Moving Average is $3.77. Nevertheless, the first resistance level for the watch stands at $6.97 in the near term. At $7.77, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.26. If the price goes on to break the first support level at $5.68, it is likely to go to the next support level at $5.19. Now, if the price goes above the second support level, the third support stands at $4.39.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are currently 89,004K shares outstanding in the company with a market cap of 548.27 million. Presently, the company’s annual sales total 240 K according to its annual income of -64,020 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -14,880 K.
